Bigger Data, Better Outcomes Healthcare Providers Can Improve Operational Decision Making By the KPMG Healthcare Data & Analytics Team: Bharat Rao, PhD, Principal Mohit Chandra, Managing Director John Weis, Director As pay-for-performance replaces fee-for-service, providers and hospitals need to do more to attract and retain patients. Providers need to focus on: transparency into the relationship between medical services and costs, reduced hospitalizations and hospital-acquired complications, fewer readmissions, and improved health outcomes. However, making all of these operational, financial, and clinical improvements may seem like a daunting task. The healthcare industry is currently undergoing a revolution fueled by the increased availability of data, similar to what the retail and financial services industries experienced in the last decade. Today, there are tools to help healthcare providers not only survive but flourish, even as the healthcare industry converges, demands for transparency increase, regulations evolve, and budgets and resources shrink. The big data tools and technologies available today can harness the power of increasingly available data. Applying advanced analytics to this data can yield actionable insights into such critical areas as provider-payer collaboration, population management, cost reduction, improved health outcomes, patient safety, physician satisfaction, and more. Within the data analytics realm, the provider community is increasingly exploring the use of large external patient-claims data sets to meet these goals. From sources like Blue Health Intelligence (BHI), State-Level All Payers Claims Database (APCD), and the Centers for Medicare and Medicaid Services (CMS), these very large data sets allow providers to understand what is happening to patients outside the four walls of their institutions. The data sets can amplify the power of data from providers’ own internal healthcare IT systems and electronic health records (EHRs). The resulting insights can help providers elevate their outcomes and maintain control of quality. And big data predictive models can be developed with these data elements to further transform the delivery of care. Although the complete transformation of the healthcare industry into a data-driven business will take many years, well-planned actions can be beneficial even today. On the journey from volume to value, big data solutions and insights can keep you on the right path. Our hope is that this issue brief will help you take the first steps in realizing institutional and patient value from the use of external data sets. © 2015 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. The KPMG name, logo and “cutting through complexity” are registered trademarks or trademarks of KPMG International. NDPPS 336084 Big data is a key part of outcome-driven analytics solutions Big data has already been in play in the provider world over the past few years. Clinical data from EHRs is being used to share information with other internal healthcare providers who might be involved in a patient’s care. Individual data sets are being mined by predictive algorithms to derive evidence-based practices and new treatment protocols. Hospitals participating in local and regional health information exchanges (HIEs) have had access to a wide range of clinical, financial, and operational data. When it comes to sharing of information with external physicians and hospitals, however, providers have been a little more reticent. There will need to be a cultural change amongst providers, since, in the fee-for-service world, there were no incentives for coordinating care or collaborating to improve outcomes. Several factors are pushing the industry toward wider use of big data. Regulatory demands for quality have awakened the provider community to the need for collaboration. Emerging technology for improved security, de-identification, and encryption are making it easier to collaborate. Costs matter more now, with the move from pay-for-service to fee-for-performance and -outcomes, including value-based payments. Providers who want to get more value out of technology upgrades and EHR purchases required for Meaningful Use and HIPAA compliance are looking for ways to build upon these investments. Practical use cases Providers may be asking themselves: What can I do with a large patient-claims data set? Below are four hypothetical scenarios that illustrate how providers can realize value from broad data sets by performing advanced longitudinal analyses across the continuum of care. A look at total reimbursement of care Situation: Providers are reinventing their practices to take on more and more financial risk for their patients. Whether it be entering into at-risk contracts, or providing health plans with justification for higher charges connected to higher-quality services, providers need to understand reimbursement patterns and clinical outcomes across the total continuum of care. A care trajectory can include several clinical episodes beyond a provider’s own treatment of a patient, such as specialist referrals, hospital stays, rehab treatments, skilled nursing care, preventive programs, home health, and more. Problem: It has been a challenge for providers to gain insight into care delivered by other medical professionals. Providers need additional data to analyze the ramifications of the care continuum to manage both financial and clinical outcomes, including potentially avoidable complications. Solution: A big data-based solution, combined with an advanced grouper that permits analysis across episodes, can allow providers to visualize and understand the total reimbursement for a given disease condition, look at care paths for their own patients and those being cared for by other providers, understand the impact of specific treatment decisions both within and outside their institutions, and conduct longitudinal data analyses of the efficacy of specific treatment pathways. Benefits: Providers will be able to evaluate potential partners in an ACO network, quantify the true cost of an episode of care, negotiate better reimbursement contracts, and understand the factors across the continuum of care that impact the clinical outcomes of their patients. 010101 101010 010101 Claims Data Medications Patient Cohorts Procedures •Analysis of total reimbursement of care (TROC) •Impact of treatment location on patient outcomes & costs • Referral patterns • Severity adjustments Phase 1 Phase 2 Phase 3 • Definition of cohorts, patient attribution to different centers • Compute TROC, outcomes for care across centers • Visualization/analytics to determine impact of care site on TROC © 2015 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. The KPMG name, logo and “cutting through complexity” are registered trademarks or trademarks of KPMG International. NDPPS 336084 Improved population health management Situation: New reimbursement models under the Affordable Care Act (ACA) require providers to reduce readmission rates and raise quality scores for patient care. categorize patients by diagnosis and symptoms to create cohorts of homologous risk; conduct predictive modeling to understand future risk; and use visualization tools to summarize and navigate these findings. Problem: Meeting these ACA mandates requires a clear understanding of which patients are most “at risk” due to such factors as treatment nonadherence, comorbidities, or difficult-to-control chronic conditions (see next use case for more information). Benefits: Providers can identify patients who are likely to fall through the cracks, focus resources on subpopulations most likely to benefit from intensive management, address gaps in treatment, and channel appropriate educational and self-care information into patient engagement programs. These efforts should increase patients’ overall health in the long run, making providers eligible for incentive payments and eliminating the risk of financial penalties under the evolving value-based healthcare system. Solution: Analytics based on external data sets, such as BHI, APCDs, and/or CMS data, when combined with the institution's own data can provide significant insights. Providers are able to compare high-risk populations based on historical data; Readmissions/chronic disease management Situation: The Centers for Medicare and Medicaid Services have enacted new penalties for hospital readmissions, making it critical for providers to track and manage patients with chronic diseases. Problem: Since penalties can be levied up to 30 days postdischarge, providers cannot rely on typical follow-up protocols. Instead, they must have a detailed, ongoing understanding of the chronic disease patient populations they serve and be able to precisely identify the patient cohorts that run the highest risk of mismanagement or acute flare-ups. Solution: Big data algorithms can mine large data sets across many providers, combined with data sets that provide insights into the continuum of care. Providers can identify the combinations of comorbidities and conditions that are likely to result in hospital admissions and readmissions for chronic illnesses, predict outcomes for at-risk subpopulations, and identify potential complications and cost outliers for different population groups. Benefits: Providers can use big data methods to create chronic disease management programs to intervene early with appropriate patients, reduce operational costs, make efficient use of existing resources, and, eventually, qualify for higher payments from payers as the industry transitions to a valuebased reimbursement model. Consistent patient safety and quality Situation: “Quality” has become more than a buzzword in healthcare. The ACA has transformed the role of quality by linking performance on select quality measures to reimbursements, potential financial penalties, and even customer retention under formal and informal star-rating systems. Problem: The task of housing and analyzing myriad quality measurements, viewing them all in an integrated manner woven around an actionable story, and analyzing their interrelationships can be overwhelming. Solution: Combining quality measures from various sources— and supplementing with external data sets to benchmark quality performance in comparable institutions and cohorts— can be a critical component of a quality dashboard solution with drill-down capabilities. Such a solution allows trending and analysis of quality metrics in a single data warehouse model. Benefits: Providers can get both a bird‘s-eye view and a targeted view of their quality measures, for internal operational decision making and ease of reporting to both internal stakeholders and external agencies. The preceding use cases are just a sampling of how providers can use large data sets to create value. Following is a broader list of care processes for which data and analytics can be useful. © 2015 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. The KPMG name, logo and “cutting through complexity” are registered trademarks or trademarks of KPMG International. NDPPS 336084 KPMG capabilities can provide actionable insights to Healthcare Providers, and help them better understand the financial and clinical impact of care processes across the continuum of care. Volume Leakage Analytics Revenue Leakage Support Provider Benchmarking Business Planning and Forecasting Market Share Analytics M&A Due Diligence Support Patient Risk Stratification Potentially Avoidable Complications Clinical Guideline Analytics Referral Patterns Analytics At-risk and ValueBased Contracting Community Health Needs Assessment KPMG and big data One of the elements that sets KPMG LLP (KPMG) apart is our large strategic investment into a Data and Analytics Solution Center. This dedicated center houses a team of leading data scientists; engagement professionals with advanced capabilities in big data, predictive analytics, optimization modeling, and analytics technologies; preconfigured analytics technology platforms; a variety of proprietary and third-party data sets, including large external reference data sets from CMS and BHI; and advanced groupers. Additionally, in 2014, KPMG made several healthcare acquisitions, including Link Analytics, one of CIO Review's “20 Most Promising Big Data Companies”; a digital and mobile transformation company (Cynergy); and an Oracle ERP implementation company serving larger providers (Zanett). All these are now integrated into KPMG Healthcare. This team provides a platform to accelerate the design and delivery of analytical solutions created in conjunction with our client engagement teams and our robust suite of data and analytics offerings. KPMG can help providers use data to thrive in the converging healthcare landscape. Unlike pure technology companies, we recognize that data and analytics are not simply about technology, but a means to an end. With additional transformational services for Revenue Cycle, Cost Analysis, Process Redesign, and more, KPMG delivers a complete service approach to our clients. Our aim is to help providers flourish in an environment of increased economic pressure and constant regulatory change, all while serving an increasingly informed consumer. KPMG’s business-problem orientation helps us zero in on the right data and apply the appropriate analytics to generate value for our clients. And, in the longer term, our business transformation approach allows us to holistically address a practice’s or hospital’s transition to a quality-driven and outcomes-based culture. KPMG can help healthcare providers use data and analytics to foster both practical solutions and business transformation focused on improved clinical and financial outcomes. About KPMG KPMG is a leader in convergence, assisting organizations across the healthcare and life science ecosystem to work together in new ways to transform the business of healthcare. With more than 20,000 U.S.-based employees, and 8,600 U.S. partners and professionals supported by a global network of firms in 155 countries, we offer a market-leading portfolio of tools and services focused on helping our clients adapt to regulatory change; design and implement new business models; and leverage technology, data, and analytics to guide them on the paths to convergence. Our professionals can assist throughout the transaction life cycle, depending on the organization's resource constraints. This can include marketplace research and thought leadership in establishing a strategic road map, as well as support with target identification, deal structuring, valuation, due diligence, and integration assistance, all helping to translate strategy to successful execution and outcomes. Contact us Bharat Rao, PhD Principal [email protected] Mohit Chandra Managing Director [email protected] John Weis Director [email protected] kpmg.com The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. © 2015 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. Printed in the U.S.A. The KPMG name, logo and “cutting through complexity” are registered trademarks or trademarks of KPMG International. NDPPS 336084
© Copyright 2024